Labeling Type
34391-3
Status
Approved
Full Title
{"br": [null, null, null, null], "sup": ["®", "®"], "#text": "These highlights do not include all the information needed to use EDURANT safely and effectively. See full prescribing information for EDURANT.\n \n \nEDURANT \n (rilpivirine) tablets, for oral use\n \nEDURANT \n PED (rilpivirine) tablets, for oral suspension\n \nInitial U.S. Approval: 2011"}
United States
Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.
